Emilda Thompson
- Pulmonary and Respiratory Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Cancer Research top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Johann S. de BonoGerhardt AttardNikhil Babu OommenElizabeth FolkerdMitch DowsettAlison ReidDavid OlmosGal Maier
- Topics
- Prostate Cancer Treatment and Research (7 papers)Radiopharmaceutical Chemistry and Applications (3 papers)Cancer, Lipids, and Metabolism (2 papers)
- Journals
- Journal of Clinical OncologyThe Journal of Clinical Endocrinology & MetabolismEuropean Urology
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Emilda Thompson
7 papers receiving 763 citations
Peers
Comparison fields: 5 of 52
- Pulmonary and Respiratory Medicine 658
- Endocrinology, Diabetes and Metabolism 292
- Cancer Research 223
- Molecular Biology 178
- Radiology, Nuclear Medicine and Imaging 164
Countries citing papers authored by Emilda Thompson
This map shows the geographic impact of Emilda Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilda Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilda Thompson more than expected).
Fields of papers citing papers by Emilda Thompson
This network shows the impact of papers produced by Emilda Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilda Thompson. The network helps show where Emilda Thompson may publish in the future.
Co-authorship network of co-authors of Emilda Thompson
This figure shows the co-authorship network connecting the top 25 collaborators of Emilda Thompson. A scholar is included among the top collaborators of Emilda Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilda Thompson. Emilda Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 69 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 215 | |
| 6 | 448 | |
| 7 | Selective inhibition of CYP17 with abiraterone acetate is well tolerated and results in a high response rate in castration-resistant prostate cancer (CRPC) | 1 |
About Emilda Thompson
Emilda Thompson is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 7 papers that have together received 766 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (658 citations), Endocrinology, Diabetes and Metabolism (292 citations) and Cancer Research (223 citations). Emilda Thompson has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Johann S. de Bono, Gerhardt Attard, Nikhil Babu Oommen, Elizabeth Folkerd, Mitch Dowsett, Alison Reid, David Olmos, Gal Maier, L. Rhoda Molife and Amy Mulick. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.